Skip to main content

Understanding Dosing Principles: Start Low, Go Slow & Consistency

GLP-1 RA therapy follows one overriding rule: start low, go slow. Beginning with a small weekly dose lets the body adapt and reduces the odds of nausea, vomiting, or diarrhea that are more common at higher levels.

1

Initiation phase (first 4 weeks)

2.5 mg subcutaneous once weekly.

Note: These starter doses mainly condition the gut and rarely deliver full glucose or weight benefits.

2

Titration (dose escalation)

After week 4 the dose usually rises to 5 mg (first therapeutic level).

Note: Further increases are made in 4-week steps if the patient tolerates the current dose and still needs stronger effect.

3

Maximum Labeled Doses

Mounjaro®: up to 15 mg weekly.

Note: Not every patient needs—or can tolerate—these ceiling doses.

4

Adjusting for side effects

If troublesome symptoms appear during titration, a clinician may hold the dose longer or step it back until side effects settle.

CRITICAL CAVEAT: Medical Supervision Is Essential​

danger

Only a qualified healthcare provider should decide when to start, raise, hold, or lower your dose. The numbers above come from standard product labels and are not a do-it-yourself schedule. Self-setting doses is dangerous, especially with products of uncertain potency (Path C).

Consistency​

Inject on the same day each week to keep drug levels steady. If you must change your injection day, follow the product instructions or ask your provider first.